Berlin, Germany

Klaus Kühne

This inventor holds 9 USPTO granted patents. Top assignees: Exentis Knowledge Gmbh, Laxxon Medical Ag, Laxxon Medical Ag Exentis Knowledge Gmbh. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Kühne. Retrieved from https://idiyas.com/inventor/klaus-kühne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Klaus Kühne: Innovator in Drug Delivery Systems

Introduction

Klaus Kühne is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of drug delivery systems, holding a total of nine patents. His innovative methods have the potential to enhance the effectiveness of medical treatments.

Latest Patents

Klaus Kühne's latest patents focus on a method for producing a drug delivery system. This method involves screen-printing a base paste and curing it. Additionally, it includes the steps of screen-printing a first paste separate from the base paste and curing that first paste as well. These advancements represent a significant step forward in the production of drug delivery systems.

Career Highlights

Throughout his career, Klaus Kühne has worked with notable companies such as Laxxon Medical AG and Exentis Knowledge GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the medical field.

Collaborations

Klaus has collaborated with esteemed colleagues, including Achim Schneeberger and Helmut Kerschbaumer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Klaus Kühne's work in drug delivery systems exemplifies the impact of innovative thinking in medicine. His patents and collaborations highlight his commitment to advancing healthcare technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…